This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Inamed Board Takes Swiss Approach

The four-way fight in the cosmetic drug and device industry moved to the next round Tuesday when Inamed (IMDC) said a takeover bid by Allergan (AGN - Get Report) is superior to a previous offer from Medicis Pharmaceutical (MRX).

However, Inamed said its board was remaining neutral and not making a recommendation to its shareholders about the Allergan bid. Inamed, based in Santa Barbara, Calif., said the board was reserving its endorsement because Allergan has made a "revised" bid that's "materially different" than last month's offer from the Irvine, Calif., maker of Botox and eye-care drugs.

Inamed also said it can't take sides because it's "unable to enter into a definitive merger agreement with Allergan reflecting the terms of the revised offer until such time, if any, as Inamed's merger agreement with Medicis is terminated."

Both Allergan and Inamed said the financial terms of Allergan's offer are identical to the original proposal. The revision concerns a formal letter, detailing legal and due diligence matters, that Allergan sent Inamed. The letter enables Inamed to accept the offer through Dec. 31. Inamed had requested an irrevocable offer letter, and Allergan complied.

"We are making excellent progress in completing the acquisition of Inamed," said David E. I. Pyott, Allergan's chairman and CEO, in a prepared statement.

Two weeks ago, Medicis issued an ultimatum to Inamed -- reject the Allergan offer by today, or Medicis could to exercise its right to seek a $90 million breakup fee. There was no immediate comment from Medicis on Tuesday.

On Nov. 21, Allergan started an exchange offer for Inamed's stock even though Inamed hadn't responded formally to its takeover bid. The tender offer expires Dec. 20. Allergan's offer is worth $84 a share, either all cash or 0.8498 shares for each share of Inamed.

Medicis, Scottsdale, Ariz., made an offer in March for $30 in cash plus 1.4205 shares for each share of Inamed. Due to fluctuating shares prices, the value of the Medicis offer has bounced around. Based on current prices, it's worth $78 a share.
1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
IMDC $0.00 -2.50%
AGN $201.37 -4.30%
MRX $0.00 0.00%
AAPL $92.54 -0.75%
FB $119.24 1.20%


Chart of I:DJI
DOW 17,715.47 +54.76 0.31%
S&P 500 2,054.55 +3.92 0.19%
NASDAQ 4,727.3670 +10.2730 0.22%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs